Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Genenta Science S.p.A. before investing.

In this article, we go over a few key elements for understanding Genenta Science S.p.A.’s stock price such as:

• Genenta Science S.p.A.’s current stock price and volume
• Why Genenta Science S.p.A.’s stock price changed recently
• Upgrades and downgrades for GNTA from analysts
• GNTA’s stock price momentum as measured by its relative strength

About Genenta Science S.p.A. (GNTA)

Before we jump into Genenta Science S.p.A.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Genenta Science S.p.A., a clinical-stage biotechnology company, develops hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company offers Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. It is developing Temferon for use in the treatment of other solid tumor indications. In addition, the company develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.

Want to learn more about Genenta Science S.p.A.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Genenta Science S.p.A..

Genenta Science S.p.A.’s Stock Price as of Market Close

As of August 21, 2026, 4:00 PM, CST, Genenta Science S.p.A.’s stock price was $1.260.

Genenta Science S.p.A. is up 5.88% from its previous closing price of $1.190.

During the last market session, Genenta Science S.p.A.’s stock traded between $1.220 and $1.290. Currently, there are approximately 24.25 million shares outstanding for Genenta Science S.p.A..

Genenta Science S.p.A.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Genenta Science S.p.A. Stock Price History

Genenta Science S.p.A.’s (GNTA) price is currently down 15.44% so far this month.

During the month of August, Genenta Science S.p.A.’s stock price has reached a high of $1.570 and a low of $1.110.

Over the last year, Genenta Science S.p.A. has hit prices as high as $10.000 and as low as $0.550. Year to date, Genenta Science S.p.A.’s stock is down 15.44%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Genenta Science S.p.A. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of August 21, 2026, there were analysts who downgraded Genenta Science S.p.A.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Genenta Science S.p.A.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Genenta Science S.p.A.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Genenta Science S.p.A. (GNTA) by visiting AAII Stock Evaluator.

Relative Price Strength of Genenta Science S.p.A.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of August 21, 2026, Genenta Science S.p.A. has a weighted four-quarter relative price strength of 15.47%, which translates to a Momentum Score of 88 and is considered to be Very Strong.

Want to learn more about how Genenta Science S.p.A. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Genenta Science S.p.A. Stock Price: Bottom Line

As of August 21, 2026, Genenta Science S.p.A.’s stock price is $1.260, which is up 5.88% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Genenta Science S.p.A. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.